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influenced by pH-neutral PD fluid. Creatinine and phosphateEffects of pH-neutral, bicarbonate-buffered dialysis fluid on
elimination appears to be slightly reduced with bicarbonateperitoneal transport kinetics in children.
fluid; this observation awaits clarification in extended therapeu-Background. Due to their superior biocompatibility, pH-
tical trials.neutral solutions are beginning to replace acidic lactate-
buffered peritoneal dialysis (PD) fluids. We hypothesized that
pH-neutral and acidic solutions might differentially affect peri-
toneal transport in the early dwell phase, due to differences in Conventional peritoneal dialysis (PD) solutions im-ionic shifts and initial peritoneal vasodilation. Such differences
pair mesothelial and local macrophage cell functions duemay become clinically relevant in patients with frequent short
to their high concentrations of lactate and glucose, acidiccycles on automated PD (APD).
Methods. Twenty-five children were treated with a lactate- buffering and the formation of toxic glucose degradation
buffered (35 mmol/L, pH 5.5) or a bicarbonate-buffered PD products (GDP) during manufacturing [1]. GDPs and
solution (34 mmol/L, pH 7.4) in randomized order on two lactate have been demonstrated to trigger the local re-sequential days. Each day a four-hour Standardized Permeabil-
lease of growth factors such as vascular endotheliality Analysis (SPA) was performed, followed by overnight APD
growth factor (VEGF) and transforming growth factor-(7 cycles, fill volume 1000 mL/m2, dwell time 75 min). Func-
tional peritoneal surface area was dynamically assessed using (TGF-), which are potent stimulators of neoangiogen-
the three-pore model. esis and fibrogenic processes [2–6]. These mechanisms
Results. While intraperitoneal pH was constant at 7.41 
are believed to contribute to peritoneal sclerosis and loss0.03 throughout the SPA with bicarbonate fluid, the dialysate
of ultrafiltration, major causes of long-term PD failureremained acidic for more than one hour with lactate solution
(pH 7.12  0.08 at 1 h). Total pore area was 60% higher [7–9].
during the first 30 minutes of the dwell than under steady-state Bicarbonate-based PD solutions are buffered at neu-
conditions, without a difference between acidic and pH-neutral tral pH and virtually free of GDPs [10]. The superior
fluid. Net base gain, intraperitoneal volume kinetics, glucose
biocompatibility of pH neutral solutions has been dem-absorption, ultrafiltration rate, effective lymphatic absorption
onstrated in numerous in vitro studies [11–16]. Recentand the transport of urea, potassium, 2-microglobulin and
albumin were similar with both fluids. However, phosphate technological advances have solved the problem of bicar-
and creatinine elimination were 10% lower with bicarbonate bonate stability, permitting the routine use of these solu-
PD fluid, resulting in corresponding significant decreases in tions in chronic PD [10].
the 24-hour clearances of these solutes.
The instillation of fresh, lactate-based PD fluid leadsConclusion. The peritoneal surface area is not measurably
to a marked initial dilatation of peritoneal capillaries,
resulting in a transient increase of the peritoneal surface
1 The authors are members of the Mideuropean Pediatric Peritoneal area available for solute transfer in the early phase of
Dialysis Study Group (MEPPS). the dwell period [17]. Experimental studies have sug-
gested that the low pH of conventional lactate-bufferedKey words: dialysate pH, bicarbonate buffer, peritoneal dialysis, phos-
phate kinetics, children, acid-base balance. PD solutions contributes to this effect [18], which van-
ishes rapidly when intraperitoneal pH is normalized byReceived for publication April 16, 2001
lactate resorption and bicarbonate efflux. If the initialand in revised form October 30, 2001
Accepted for publication October 31, 2001 local acidosis is indeed responsible for the early increase
in functional peritoneal surface area, alterations of peri- 2002 by the International Society of Nephrology
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toneal transport kinetics may be expected with pH-neu-
tral PD fluids. Given the rapid reversibility of the initial
vasodilatation, it is not surprising that similar solute and
water transport characteristics were observed with acidic
lactate and pH-neutral bicarbonate-buffered dialysis
fluid in patients on CAPD with dwell times ranging be-
tween 3 and 12 hours [19]. However, differences might
become apparent in patients receiving repeated short
dialysis cycles on automated PD (APD), who are ex-
posed to an acidic milieu for much of the treatment time.
Moreover, pH-neutral and acidic solutions may differ in
Fig. 1. Peritoneal dialysis (PD) protocol during a study day. The identi-the clearance of ionized solutes with an isoelectric point
cal protocol was applied on two subsequent days, using lactate- oraround the physiological pH, where the ionization state bicarbonate-based PD solution in randomized order. The black squares
changes in acidic but not in pH-neutral dialysate. Again, reflect time points of arterialized capillary blood gas analysis (BGA).
Abbreviations are: BSA, body surface area; SPA, standard peritonealsuch differences may only become apparent in patients
permeability analysis; APD, automated peritoneal dialysis.on APD.
Since APD is the predominant PD modality in children
and children may be particularly sensitive to changes in
peritoneal transport kinetics, we investigated a cohort antibodies was negative in all patients; none of the pa-
tients had been treated with dextran in the past.of pediatric patients to determine whether exposure to
a more biocompatible, bicarbonate-based, pH-neutral
Study designPD fluid affects peritoneal solute transport kinetics as
compared with standard acidic lactate-based solution. Sodium bicarbonate substitution and phosphate binder
treatment was discontinued five days prior to the study.The statistical power of the investigation was maximized
by an intraindividual comparison of solute and water The remaining medication was kept constant throughout
the study. The patients were hospitalized for the study,transport rates, assessed both by a detailed peritoneal
equilibration assessment and by standardized overnight which was performed on two consecutive days. In the
night before the first study day, all patients performedcycler dialysis performed with either solution on subse-
quent days. their regular APD regimen, using standard lactate-based
PD fluids. In the morning of each study day, a four-hour
standard peritoneal permeability analysis (SPA) was
METHODS
performed, followed by a prolonged daytime dwell and
Patients a standardized overnight cycler dialysis (Fig. 1). In each
patient, a lactate-buffered solution (35 mmol/L lactate,Twenty-five children (18 boys and 7 girls) on APD
participated in the study. The patients were treated in pH 5.5; CAPD17; Fresenius Medical Care, Bad Hom-
burg, Germany) was used for all procedures on one day,five pediatric dialysis centers in Germany. The underly-
ing diseases were hemolytic uremic syndrome (N  4), and a bicarbonate-buffered solution on the other day
(34 mmol/L bicarbonate, pH 7.4; BIC170; Fresenius) inrenal hypo-/dysplasia (3), obstructive uropathy (3), focal
segmental glomerulosclerosis (2), nephronophthisis (2), randomized order. Thirteen patients received the bicar-
bonate solution on the first and the lactate solution onautosomal recessive polycystic kidney disease (2), prune
belly syndrome (2), Jeune syndrome (2), membranoprol- the second day, and 12 patients vice versa.
The SPA was performed as described by Pannekeetiferative glomerulonephritis type II (1), Alport syn-
drome (1), Wegener’s granulomatosis (1), and unknown et al [20] using bags containing 1.5% glucose. One gram
per liter of Dextran 70 (Hyskon, Pharma Reusch, Bonn,(2) patients. Children with severe pulmonary, cardiac or
liver disease were excluded from the study. The patients Germany) was added to each bag. To prevent possible
anaphylactic reactions to dextran [21], 50 mg/kg Dextranwere aged 1.1 to 18.3 (median 11.7) years. Duration of
peritoneal dialysis treatment was 1 to 53 (median 7) 1 (Promit, Pharma Reusch) was given intravenously
prior to instillation of the test solution. The peritonealmonths, and seven patients had experienced at least one
episode of peritonitis. In these patients the last peritonitis cavity was rinsed with 500 mL/m2 body surface area
(BSA) of the dextran-containing test solution and imme-had occurred 2 to 15 (median 9) months prior to the
study. Nine patients were anuric; the patients with resid- diately drained by gravity after the inflow was completed.
Then, 1000 mL/m2 BSA of the same test solution wereual renal function had a urine output of 60 to 1680 (me-
dian 530) mL/day and a residual glomerular filtration instilled for four hours. At 10, 20, 30, 60, 120, 180 and
240 minutes, 10% of the dwell volume were temporarilyrate (mean of creatinine and urea clearance) of 0.1 to
8.5 (median 3.4) mL/min/1.73 m2. Screening for dextran drained to avoid dead-space effects, 3 mL of dialysate
Schmitt et al: Peritoneal kinetics with pH-neutral PD fluid 1529
collected, and the dialysate re-infused. After complete Calculations
drainage at 240 minutes, the peritoneal cavity was rinsed The residual peritoneal volume (Vr) was calculated as
with 500 mL/m2 BSA of the test solution without the described earlier [24]. Mean residual volume was 79 
dextran supplement. 25 mL/m2, accounting for about 8% of the fill volume
The subsequent daytime dwell consisted of 500 mL/ during SPA and overnight APD.
m2 of the corresponding dextran-free lactate- or bicar- The mass transfer area coefficients (MTAC) during
bonate-containing solution. The glucose content (1.5 or the SPA were calculated for each solute using two differ-
2.3%) was chosen according to clinical requirements but ent models:
was kept constant for the two study days.
(1) Model of Popovich, Pyle and Moncrief [25]:During the night following the SPA the patients re-
ceived standardized cycler PD (7 cycles, 1000 mL/m2 MTACp (mL/min/1.73 m2)  Vg/t * lnBSA of dextran-free solution, 75-min dwell time). The
[(1  Dt/P)/(1  (Vir * D0/Vg/P))]glucose concentration (1.5 or 2.3%) was again chosen
according to individual requirements and kept constant
* 1.73/BSA (Eq. 1)
during the study.
where Vir  Vi  Vr, (Vi  volume instilled), Vdr  Vd Blood samples and capillary blood gas analyses were
Vr (Vd  volume drained), and Vg is the geometric meanobtained at 0 and 240 minutes of the SPA and before
of Vir and Vdr. Dt is the dialysate concentration of theand after the overnight cycler dialysis (10 pm, 8 am). To
solute after 240 minutes, and D0 the dialysate concentra-arterialize capillary blood flow, vasodilating ointment
tion of the solute at t  0. P is the corresponding meancontaining nonivamide and nicoboxil (Finalgon; Tho-
plasma concentration, and BSA the body surface area.mae, GmbH, Biberach, Germany) was administered lo-
cally 30 minutes before sampling.
(2) Garred model as modified by Krediet et al [26]:Ethical committee approval for the study protocol was
obtained in each center. Written informed consent was MTACG (mL/min/1.73 m2)  Vd/t * ln
obtained from the parents, and assent from the patients. [Vi * P/(Vd * (P  Dt))] * 1.73/BSA (Eq. 2)
Assays The intraperitoneal fluid volume (Vip) was calculated
at each time point (t) from the outflow dextran concen-All samples were kept frozen at 20C until assaying.
tration (Cdt): Vip Vi/(Cdt); where Vi  1000 mL/m2 BSALaboratory analyses were all performed centrally at the
containing 1 g/L of dextran 70.laboratory of the University Children’s Hospital, Heidel-
Glucose absorption was calculated as the differenceberg. Blood and dialysate glucose, creatinine, urea, lac-
between the amount of glucose instilled and the amounttate, electrolytes, inorganic phosphate, enzymes, total
recovered, relative to the amount instilled.protein, triglyceride, cholesterol albumin and beta2-micro-
The effective lymphatic absorption rate (ELAR) wasglobulin (2m) were measured using standard labora-
calculated from the dextran disappearance rate by divid-tory methods. Dialysate creatinine measurements were
ing the difference between the instilled (Dxi) and thecorrected for the presence of glucose as described pre-
recovered dextran mass (Dxr) by the geometric mean ofviously [22].
the dialysate dextran concentration (Dxgeomt):Dextran concentrations were determined in the test
ELAR (mL/min)  (Dxi  Dxr)/(Dxgeom)t (Eq. 3)bag, in each sample of the SPA and in the effluents of
the two rinse solutions. Dextran 70 concentrations were For the calculation of Kt/V urea, total body water
measured by a procedure published earlier [23]. In brief, estimates based on height and weight were made using
samples were deproteinized with trichloroacetic acid and the pediatric equations of Cheek, Mellits and Elliott [27].
dextran pre-extracted using a Sephadex G-25 PD-10 col- The total pore area over diffusion distance (A0/x)
umn. Thereafter, high-pressure liquid chromatography was calculated by use of the three-pore model [28] from
(HPLC) was performed using a Bio-Gel XL guard col- the dialysate and plasma concentrations of sodium, urea,
umn coupled to a Hewlett-Packard refraction index de- creatinine, and glucose. A detailed description of the
tector. Blood and dialysate pH, pCO2 and pO2 were equations is in [29]. In the present study, the analysis
measured using a blood gas analyzer (ABL 50; Radiome- of A0/x was developed further. All D/P concentration
ter, Copenhagen, Denmark), and actual bicarbonate ratios and D/D0 for glucose of a particular SPA study,
concentrations were calculated from the Henderson- either with bicarbonate or lactate, were used in the analy-
Hasselbach equation. To exclude matrix effects, the acid- sis. In total 32 data pairs were obtained for the four
base status of the dialysate also was assessed by back solutes (all except protein) at each of eight different
dwell times (0, 10, 20, 30, 60, 120, 180, and 240 min).titration analysis (Mieha; Struers, Willich, Germany).
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Table 1. Biochemical characteristics of 25 pediatric APD patients quential investigation of each patient with bicarbonate-
and lactate-based PD fluid in randomized order was notParameter MeanSD
associated with any carryover effects, as evidenced by aSerum creatinine mg/dl 8.93.4
Blood urea nitrogen mg/dl 4913 lack of differences in biochemical parameters between
Hematocrit % 314.7 patients studied after overnight APD with bicarbonate-
Serum albumin g/L 36.26.3
or lactate-based PD fluid, respectively.Serum alkaline phosphatase U/L 461323
Serum phosphate mmol/L 1.880.6
Capillary pH 7.400.06 Standardized permeability assessment
pCO2 357
Intraperitoneal pH kinetics were substantially differ-Standard bicarbonate 21.43.6
Base excess 2.53.5 ent for more than one hour using the two PD solutions
(Fig. 2). Whereas intraperitoneal pH remained constant
at 7.41  0.03 throughout the four-hour dwell with the
bicarbonate solution, pH was still in the acidic range
The best fit between measured and modeled D/P and with the lactate fluid after one hour (7.12  0.08, P 
D/D0 concentration ratios was obtained by numerical 0.05). Net base absorption did not differ after one and
integration. To evaluate the effect of the initial vasodila- four hours of SPA (Table 2).
tion on the area (A) parameter, A0/x was calculated The pCO2 of the bicarbonate solution was 55  23
not only for the steady-state, but also for the dynamic mm Hg at the beginning of the SPA, decreasing to 41 
non-steady state condition early (that is, 10 to 30 min 8 mm Hg after 20 minutes. Arterialized blood pCO2 was
dwell time) and late (120 to 240 min) during the dwell. not affected by the increased pCO2 of the bicarbonate
Thus, steady-state A0/x is obtained using the following, dialysis fluid.
previously derived equation [30, 31]. The calculated The results regarding peritoneal solute transport dur-
steady-state A0/x accounts for vasodilation: ing the SPA are given in Table 2 and Figure 3. D/P
creatinine was significantly higher with lactate than withA0
x
(t) 
A0
x
· (1  e0.08·t) (Eq. 4) bicarbonate solution at 30 minutes (0.31 0.07 vs. 0.27
0.08, P  0.05), one (Table 2) and two hours (0.58 
where A0/x(t) is the area parameter at a given time 0.10 vs. 0.53  0.12, P  0.05), but not at four hours.
calculated from the steady-state A0/x. According to the Independently of the model used, the difference in
equation, A0/x(t) after 30 minutes is already close to MTAC creatinine did not achieve statistical significance.
the steady-state value (9%), despite an initial 100% D/P phosphate was not higher with lactate than with
increase. The non-steady-state A0/x value obtained bicarbonate dialysis fluid at 30 minutes (0.22  0.06 vs.
without using this equation gives the value relevant for 0.20  0.07, P  0.27) and two hours (0.41  0.08 vs.
a specific time interval, such as, A0/x (t 10 to 30 min). 0.39 0.11, P 0.16), but at one and four hours (Table 2).
The observed differences in the corresponding MTACG/PStatistical analysis
of phosphate did not reach statistical significance (P 
Data are given as mean  SD. The intraindividual 0.17 and 0.08, respectively). The transport characteristics
differences in acid-base status and transport parameters of urea, and the middle and large molecule markers 2mobserved between the lactate-buffered and the bicarbon- and albumin did not differ between the two solutions.
ate-buffered PD fluid were evaluated for significance by
Furthermore, glucose absorption was identical through-
paired Student t tests. Data were considered significant
out the four hours, with a mean glucose uptake of ap-with a P value 0.05.
proximately 9 g/m2 BSA. Accordingly, the intraperito-
neal volume change and net ultrafiltration rates were
RESULTS comparable with either PD solution.
The baseline biochemical characteristics of the patient
Overnight APDgroup are given in Table 1. The acid-base status was in
The clearances achieved by overnight APD using ei-the normal range in all but five subjects, who displayed
ther the lactate or bicarbonate PD solution reflected themild metabolic acidosis (pH 7.30 to 7.35). Nine patients
SPA results (Table 3). On average, APD creatinine andhad increased plasma phosphate levels between 2.0 and
phosphate clearances were slightly lower when bicarbon-2.92 mmol/L. There were no differences in baseline val-
ate fluid was used, with borderline statistical significanceues between patients started with the bicarbonate or the
(12%, P  0.06, and 10%, P  0.07, respectively).lactate solution. Residual urinary phosphate excretion
In contrast, urea and potassium clearances as well as thewas similar during the two days of the study (2.32 2.08
2m and albumin elimination rates did not differ duringmmol/m2 * day using lactate dialysate and 2.63  2.40
mmol/m2 * day using the bicarbonate solution). The se- the two test nights. Also, overnight glucose absorption
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Fig. 2. Lactate, bicarbonate and pH equilibration in 25 pediatric patients treated with acidic lactate-buffered or pH-neutral bicarbonate-buffered
PD solution. Data are mean  SD. (A) Base fluxes with lactate solution. (B) Base fluxes with bicarbonate solution. Symbols are: () dialysate
over plasma (D/P) bicarbonate (left ordinates); () D/P lactate (right ordinates). (C) Course of dialysate pH during a four-hour dwell period.
Symbols are: () curve obtained with bicarbonate PD fluid; () curve with lactate PD fluid.
and total net ultrafiltration were identical with the lactate
and the bicarbonate solution.
The reciprocal transperitoneal base fluxes of lactate
and bicarbonate were predictably much greater with the
lactate than with the bicarbonate dialysis solution. How-Table 2. Results of standard peritoneal permeability analysis
performed with bicarbonate- and lactate-based PD fluids ever, the net total base gain during overnight APD was
the same with lactate and bicarbonate fluid.Bicarbonate Lactate
Blood pH was identical before and after the 10 hours1h D/P creatinine 0.380.10 0.420.08a
4h D/P creatinine 0.730.13 0.770.11 of APD both with bicarbonate (7.40  0.05 vs. 7.40 
MTACP creatinine mL/min/1.73 m2 10.43.8 11.94.5 0.05) and with lactate PD fluid (7.39  0.05 vs. 7.40 
MTACG creatinine mL/min/1.73 m2 9.83.7 11.14.5
0.05, NS). Calculated plasma bicarbonate was 21.8  3.3
1h D/P urea 0.590.09 0.580.09 before and 22.2 3.5 mmol/L after APD with bicarbon-4h D/P urea 0.930.07 0.920.11
ate (NS), and 22.6  3.2 before and 22.2  3.2 mmol/LMTACP urea mL/min/1.73 m2 21.56.5 23.19.6
MTACG urea mL/min/1.73 m2 21.06.3 21.89.8 APD with lactate PD fluid (NS).
1h D/P phosphate 0.270.08 0.300.07a
4h D/P phosphate 0.560.11 0.600.10a Twenty-four hour CCPD
MTACP phosphate mL/min/1.73 m2 6.491.94 7.102.12
An intensive continuous cycling peritoneal dialysisMTACG phosphate mL/min/1.73 m2 5.952.14 6.412.24
(CCPD) schedule was performed on each study day,1h D/P potassium 0.530.10 0.540.11
4h D/P potassium 0.810.09 0.800.12 which consisted of the 4-hour SPA, a 10-hour daytime
MTACP potassium mL/min/1.73 m2 14.04.48 12.74.66 dwell, and 10 hours of APD. The total dialytic soluteMTACG potassium mL/min/1.73 m2 13.54.36 11.94.51
clearances and ultrafiltration rates are given in Table
4h 2-microglobulin clearance
3. The daily creatinine and phosphate clearances weremL/min/1.73 m2 1.320.81 1.311.03
4h albumin clearance mL/min/1.73 m2 0.1270.066 0.1280.053 decreased by approximately 10% with the bicarbonate
solution (P  0.05 for both comparisons), whereas no1h D/D0 glucose 0.660.11 0.650.07
4h D/D0 glucose 0.350.11 0.340.09 differences were observed for any of the other dialytic
4h glucose absorption g/m2 9.12.1 9.01.7 solute removal rates, cumulative peritoneal glucose ab-MTACP glucose mL/min/1.73 m2 9.593.88 8.552.41
sorption or total ultrafiltration. Also, the net daily acid-
1h ultrafiltration mL/m2 112117 126100
base balance did not differ between the bicarbonate and4h ultrafiltration mL/m2 10089 11887
the lactate solution.Effective lymphatic absorption
rate mL/min/1.73 m2 1.941.65 1.582.01
Total pore area over diffusion distance, A0/x4h bicarbonate flux mmol/m2 6.02.84 24.83.4
4h lactate flux mmol/m2 0.90.3 30.22.3 Agreement between measured and modeled D/P or
4h-net base flux mmol/m2 5.12.9 5.43.1 D/D0 values was excellent, as shown in the Bland-Altman
Mass transport area coefficients were calculated by the model by Pyle and analysis of a representative patient (Fig. 4). There wasPopovich (MTACP) and the Garred model modified by Krediet (MTACG).
a P  0.05 a larger intraindividual variability in the A0/x values
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Fig. 3. Solute mean equilibration curves observed with bicarbonate-buffered () and lactate-buffered PD fluid (). (A) Dialysate over plasma
(D/P) creatinine, (B) D/P urea, (C) D/P phosphate, (D) dialysate over baseline dialysate (D/D0) glucose. Data are mean  SD.
when the paired SPAs (bicarbonate vs. lactate tests) were
considered: the test-retest coefficient of correlation was
r  0.60 (P  0.05), and the coefficient of variation,
16.9%.
Table 3. Efficacy of overnight APD and total 24-hour CCPD with The mean steady-state A0/x of the 25 children wasbicarbonate - vs. lactate-based PD fluid
26,500  9,800 cm2/cm/1.73 m2 BSA with bicarbonate-
Bicarbonate Lactate based PD fluid, and 28,200  7,900 cm2/cm/1.73 m2 BSA
Creatinine clearance with the lactate solution (NS; Fig. 5). Separate analysis
Overnight APD mL/min/1.73 m2 8.12.2 9.22.1 of the early and the late dwell phase showed a markedly
24-hour CCPD L/week/1.73 m2 50.011.1 55.910.6a
higher A0/x during the first 30 minutes of the dwell,Kt/Vurea
Overnight APD per 10 h 0.270.06 0.270.06 which was only slightly lower with bicarbonate (42,700 
24-hour CCPD per week 2.560.50 2.560.53 13,700) than with lactate fluid (45,600  12,000 cm2/cm/
Phosphate clearance
1.73 m2, NS). During the late phase of the dwell theOvernight APD mL/min/1.73 m2 7.011.79 7.712.01
24-hour CCPD L/week/1.73 m2 42.38.9 46.39.7b non-steady state A0/x decreased significantly both with
Potassium clearance lactate and bicarbonate fluid (each P  0.01) to valuesOvernight APD mL/min/1.73 m2 10.42.39 10.52.1
indifferent from the steady-state area.24-hour CCPD L/week/1.73 m2 60.411.0 60.39.5
Albumin elimination
Overnight APD g/m2/10 h 1.430.73 1.260.59
24-hour CCPD g/m2/day 2.811.02 2.440.86 DISCUSSION
2m elimination
This study represents the first systematic applicationOvernight APD g/m2/10 h 11.47.4 11.610.8
24-hour CCPD g/m2/day 30.913.9 32.722.3 of a pH-neutral, bicarbonate-buffered PD solution in
Glucose absorption children, to our knowledge. We also provide the firstOvernight APD g/m2/10 h 43.118.3 44.919.8
detailed analyses of functional peritoneal surface area,24-hour CCPD g/m2/day 61.120.9 62.420.9
Ultrafiltration rate intraperitoneal pH kinetics and transport kinetics with
Overnight APD mL/m2/10 h 513289 604230
a pH-neutral dialysis fluid.24-hour CCPD mL/m2/day 669368 749281
Bicarbonate flux The main hypothesis evaluated in this trial was that a
Overnight APD mmol/m2 32.324.8 99.319.1 pH-neutral PD fluid might affect early water and solute
24-hour CCPD mmol/m2/day 44.127.3 13622
transport kinetics due to a less marked peritoneal vasodi-Lactate flux
Overnight APD mmol/m2/10 h 2.81.1 14036 lation and different ionic shifts. We reasoned that in
24-hour CCPD mmol/m2/day 4.91.4 18234 patients exposed to frequent short-term dwell periods
Acid-base balance
on APD, cumulative clearance and ultrafiltration ratesOvernight APD mmol/m2/10 h 30.624.4 41.734.9
24-hour CCPD mmol/m2/day 40.227.7 46.428.2 might differ between acidic and pH-neutral PD fluids as
PD protocols are in the Methods section. Glucose concentrations of PD fluids a result of these effects.
were kept constant in each subject during the entire two study days; 1.5% glucose Our monitoring of dialysate pH showed that with stan-was used in 16 patients, 2.3% in 5 and a mixture of both in 4 patients.
aP  0.05; bP  0.01 dard lactate PD fluid the peritoneal tissues are exposed
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Fig. 4. Differences between measured and
calculated D/P urea, creatinine and phos-
phate, and D/D0 glucose ratios versus means
of estimated and calculated values in a rep-
resentative patient. Symbols are data pairs
observed with () lactate solution and ()
bicarbonate fluid. The Bland Altman analysis
reflects excellent agreement between mea-
sured and modeled D/P values.
validation study [32], and probably reflects inevitable
biological variation of assumed constants in the model,
such as state of hydration, intra-abdominal hydrostatic
pressure, etc. During the first 30 minutes of the four-
hour dwell, the non-steady state total pore area was
increased by 60% compared to the second half of the
dwell, confirming previous findings obtained with a simi-
lar analytical approach in children [29]. Our results are
also in keeping quantitatively with previous clinical stud-
ies [summarized in 33, 34], which showed a transient
increase of the diffusive mass transport coefficients of
small molecules such as urea, creatinine and glucoseFig. 5. Comparison of A0/x calculated for steady-state (SS10-240) and
by approximately 60%. Using a distributed model ofnon-steady-state condition during early (nSS10-30) and late dwell phase
(nSS120-240), respectively. Symbols are: lactate-buffered solution; peritoneal transport, Waniewski, Werynski and Lind-
() bicarbonate-buffered solution; **P  0.01 and ***P  0.001. holm estimated that a twofold rise in diffusive mass trans-
port coefficients could be explained by a sixfold increase
in peritoneal blood flow [34]. An experimental investiga-
tion in cats showed that standard PD fluid (in comparisonto an acidic milieu for more than one hour, before lactate
with Tyrode solution) induces a selective increase ofabsorption and bicarbonate diffusion into the PD fluid
blood flow to the mesentery and intestinal serosa, with-result in peritoneal pH equilibration. In contrast, pH
out a change in total abdominal organ perfusion [35].remained in full equilibrium throughout the dialysis cycle
Hence, blood flow seems to be redistributed to a thinwith bicarbonate-buffered solution. This confirms that
tissue layer in immediate contact with the dialysate, sug-due to their typically short dwell times, APD patients are
gesting the presence of vasodilatory substances in theexposed to a much lower time-averaged intra-abdominal
PD fluid. The identical early increase in total peritonealpH than CAPD patients, and should be the most interest-
pore area observed with acidic lactate and pH-neutraling population to screen for differential effects of pH-
bicarbonate solution in this study provides evidence thatneutral versus acidic PD solutions in terms of solute
neither dialysate acidity nor lactate per se are rate-lim-kinetics as well as long-term biocompatibility.
iting factors determining the initial peritoneal hyperper-We applied the three-pore model to compare dynamic
fusion. Alternative mechanisms of the proposed initialchanges in the functional peritoneal surface area with
vasodilatation include an effect of glucose hyperosmolar-the two solutions. The excellent fit of measured and
ity, effects of reactive GDPs present in the PD fluid, orpredicted solute equilibration ratios demonstrates the
other effects of glucose per se. A role for glucose and/orsuitability of the model algorithm. The day-to-day vari-
ability of the area estimate was similar as in a previous its degradation products is supported by the finding that
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the degree of peritoneal hyperperfusion depends on the gradient (C), the diffusive clearance will be increased.
An estimate based on the D/P concentration ratios forglucose concentration of the PD fluid [35], and by the
differential effects of glucose, glycerol and amino acids phosphate and the pH at different times suggests that
the “buffering effect” may account for a 10 to 20% in-on early solute transport observed in a clinical study [33].
Our results argue against a major impact of GDPs, since crease of phosphate clearance.
Secondly, cellular phosphate clearance is known to bethese are present in much lower concentrations in the
double-chamber bicarbonate fluid bags than in the con- affected by variations of the acid-base status. Alkalosis
causes a shift of phosphate ions from extra- to intracellu-ventional lactate fluid [10]. Hence, our findings indirectly
support the concept that the early hyperperfusion ob- lar compartments [38], decreasing their availability for
dialytic elimination. Conversely, acidosis prevents intra-served during a dialysate dwell is caused by the hyperos-
molality as such or the high glucose concentration of the cellular phosphate sequestration, and a lowering of pH
has been demonstrated to increase phosphate removalPD fluid but not by the dialysate acidity, the GDP con-
tent or lactate per se. by hemodialysis [39, 40]. Although we did not observe
any difference in blood pH after repeated 70-minute PDThe water and solute transport kinetics are generally
in keeping with data obtained with lactate PD solution cycles on APD, it cannot be ruled out that blood pH
may transiently decrease during the first hour of thein adults [20] and children [36]. In accordance with the
similar dynamics of the functional pore surface area ob- dwell period with the acidic lactate, but not with bicar-
bonate PD fluid, resulting in differences in transcellularserved with both PD fluids, no differences were observed
with respect to the overall transport rates of glucose, phosphate fluxes and/or binding of phosphate to plasma
proteins. Alternatively, this mechanism may be confinedurea, potassium, 2m and albumin. In a recent clinical
trial in adults using a pH-neutral bicarbonate-lactate to local phosphate release from the mesothelial cells
exposed to an acidic milieu early after instillation of themixture, Tranaeus observed a small but significant in-
crease in daily ultrafiltration rates compared to standard lactate, but not the pH-neutral bicarbonate fluid.
The observed difference in creatinine transport isacidic lactate solution [37]. In our pediatric study using
a pure bicarbonate solution, no difference in the four- more difficult to explain. Creatinine is an electroneutral
molecule without significant protein binding. It is ofhour PET, overnight APD or total 24-hour CCPD ultra-
filtration was observed. However, there were a few subtle larger molecular size and eliminated less rapidly across
the peritoneal membrane than urea. Creatinine is distrib-and selective differences in transport kinetics between
the pH-neutral and the acidic PD fluid, which achieved uted both extra- and intracellularly, with a 50% slower
cellular clearance than urea [41]. The regulation of trans-significance due to the high statistical sensitivity of intra-
individual comparisons. Phosphate and creatinine trans- cellular creatinine transport is unknown; pH-dependent
differences in creatinine release from cellular constit-port rates were significantly lower at one-hour dwell
time with the bicarbonate fluid, resulting in reductions uents of the peritoneal membrane in the early dwell
phase might contribute to the observed difference in theof overnight APD and total CCPD clearances by approx-
imately 10%. Some of the differences were of borderline D/P creatinine ratios, which were significant as early as
30 minutes after instillation of the pH neutral versus thesignificance, and should be viewed with caution due to
the possibility of false-positive errors inherent to multi- acidic fluid.
Due to the more rapid peritoneal equilibration of ureaple statistical testing. However, the consistent trend to-
ward slower phosphate and creatinine equilibration in than of creatinine, patients receiving short cycles on
APD tend to have a higher urea relative to creatininethe repetitive D/P measurements, contrasting with iden-
tical equilibration rates for several other solutes mea- clearance compared to patients on CAPD [42]. The PD
adequacy guidelines of the Dialysis Outcomes Qualitysured in the same samples during the SPA, supports the
validity of the findings. Initiative (DOQI) do not account for the differential
effect of short dwell times on the two small-moleculeThe consistently reduced phosphate clearance with
the pH-neutral solution may be explained by several marker clearances, making it more difficult to achieve
the creatinine clearance than the Kt/V urea targets inmechanisms: Firstly, phosphate could be acting as a
buffer in acidic PD fluids. At physiological pH, that is, patients on APD [43]. If the relative decrease in creati-
nine clearance observed here in APD patients is con-in plasma, 80% of the phosphate is present as HPO24 ,
but equal concentrations of H2PO4 and HPO24 are ex- firmed in long-term clinical trials, the use of pH-neutral
PD fluids could have some implications for the dose ofpected when pH is 6.8. Hence, with acidic PD fluids phos-
phate will diffuse from blood to dialysate as HPO24 , where PD required to meet the recommended dialytic creati-
nine clearances.it will bind a proton and be converted to H2PO4 . As a
result, the concentration gradient for HPO24 will not be In summary, we demonstrate that pH-neutral fluids
avoid intraperitoneal acidity, which is present for muchdiminished as rapidly as for other solutes. Since the flux
of a solute is related to its MTAC and the concentration of the dwell time in APD patients treated with conven-
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bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysistional acidic lactate solutions. A transient increase in
fluids improves ex vivo peritoneal macrophage function. Am J
functional peritoneal surface area occurs during the first Kidney Dis 35:112–121, 2000
14. Rippe B, Simonsen O, Heimburger O, et al: Long-term clinical30 minutes of a dwell independently of pH and the pres-
effects of a peritoneal dialysis fluid with less glucose degradationence of lactate and GDPs. Consequently, peritoneal mass
products. Kidney Int 59:348–357, 2001
transport kinetics are similar with bicarbonate and lac- 15. Jones S, Holmes CJ, Krediet RT, et al: Bicarbonate/Lactate Study
Group: Bicarbonate/lactate-based peritoneal dialysis solution in-tate fluid for water and most solutes. Statistically signifi-
creases cancer antigen 125 and decreases hyaluronic acid levels.cant differences in creatinine and phosphate transport
Kidney Int 59:1529–1538, 2001
rates were observed; however, the clinical relevance of 16. Lage C, Pischetsrieder M, Aufricht C, et al: First in vitro and
in vivo experiences with Stay-Safe Balance, a pH-neutral solutionthese observations needs to be assessed in extended clini-
in a dual-chambered bag. Perit Dial Int 20(Suppl 5):S28–S32, 2000cal trials.
17. Carlsson O, Rippe B: Enhanced peritoneal diffusion capacity of
51Cr-EDTA during the initial phase of peritoneal dialysis dwells:
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